Breakthrough Results with MCP for Prostate Cancer
Prostate cancer is the second most common cause of cancer-related death in men. While there have been several diagnostic and treatment advancements in recent years, the options for men with biochemically relapsed prostate cancer (BRPC), an aggressive form of the disease, have historically been limited — until now. According toRead